Evidence map›Paper›PMID 30518755›Full record

ArticleEmerging microbes & infections2018

Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route.

Junping Zhu, Ning Chen, Shuya Zhou, Kai Zheng, Lin Sun, Yuxiao Zhang, Lina Cao, Xiaoyan Zhang, Qiaoyan Xiang, Zhiyun Chen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. A practical method for evaluating theEmerging microbes & infections · 2021
    Article
  5. Review
  6. Cellular receptors for enterovirus A71.Journal of biomedical science · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Junping ZhuDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Ning ChenDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Shuya ZhouDivision of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, 100050, China.
Kai ZhengDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Lin SunDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Yuxiao ZhangDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Lina CaoDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Xiaoyan ZhangDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Qiaoyan XiangDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Zhiyun ChenDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China.
Chenfei WangDivision of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, 100050, China.
Changfa FanDivision of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, 100050, China. fancf@nifdc.org.cn.
Qiushui HeDepartment of Medical Microbiology, Capital Medical University, Beijing, 100069, China. qiushui.he@ccmu.edu.cn.
Capital Medical University · CNNational Institutes for Food and Drug Control · CN

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2017ZX10202101-004Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2017ZX103304402Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) 7172016
6 · The paper itself

Abstract

Enterovirus A71 (EV-A71) is a major etiological agent of human hand, foot and mouth disease, and it can cause severe neurological complications. Although several genotypes of EV-A71 strains are prevalent in different regions of the world, the genotype C4 has circulated in mainland China for more than 20 years. The pathogenicity of different EV-A71 clinical isolates varies and needs to be explored. In this study, hSCARB2 knock-in mice (N = 181) with a wide range of ages were tested for their susceptibility to two EV-A71 strains with the subgenotypes C4 and C2, and two infection routes (intracranial and venous) were compared. The clinical manifestations and pathology and their relationship to the measured viral loads in different tissues were monitored. We observed that 3 weeks is a crucial age, as mice younger than 3-week-old that were infected became extremely ill. However, mice older than 3 weeks displayed diverse clinical symptoms. Significant differences were observed in the pathogenicity of the two strains with respect to clinical signs, disease incidence, survival rate, and body weight change. We concluded that hSCARB2 knock-in mice are a sensitive model for investigating the clinical outcomes resulting from infection by different EV-A71 strains. The intracranial infection model appears to be suitable for evaluating EV-A71 neurovirulence, whereas the venous infection model is appropriate for studying the pathogenicity of EV-A71.

Indexed as

Disease Models, AnimalAdministration, IntravenousAge FactorsAnimalsAntigens, ViralBrainEnterovirus A, HumanEnterovirus InfectionsGene Knock-In TechniquesGenotypeHumansLysosomal Membrane ProteinsMiceReceptors, ScavengerSkullViral LoadAntigens, ViralLysosomal Membrane ProteinsReceptors, ScavengerSCARB2 protein, human

Identifiers

PMID30518755
PMCPMC6281673
OpenAlexW2903417251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.